Presentation day of the Complementary Health Plan at the Carlos III Health Institute

During this Conference, Valentín Ceña presented line of action 5 at the University of Castilla-La Mancha: “Pharmacological characterization of nanoparticles” in collaboration with the Singular Center for Research in Molecular Medicine and Chronic Diseases (USC) and CICbioGUNE focused on treatment of glioblastoma with nanoparticles.

Jornada de presentación del Plan Complementario en Salud en el Instituto de Salud Carlos III